[Presentation Report] The Antimicrobial Resistance Summit Asia (December 5, 2019, Singapore)
date : 12/17/2019
Tags: AMR
On December 5, 2019, Health and Global Policy Institute (HGPI) CEO and Board Member Mr. Ryoji Noritake attended the Antimicrobial Resistance Summit Asia held by The Economist in Singapore.
Antimicrobial Resistance, or AMR, refers to the phenomena by which bacteria become immune to antimicrobial treatments over time as those treatments are used more and more. Infectious diseases brought on by antimicrobial resistant bacteria can be difficult to treat, and can even be fatal in worst case scenarios.
The problem of AMR is worsening across the world. If current trends continue, it is estimated that by 2050, as many as 10 million people could potentially die of AMR-related causes globally every year.
Mr. Noritake spoke at the panel discussion on AMR and the Sustainable Development Goals in Asia. His remarks included an introduction of the activities of AMR Alliance Japan, established in November 2018 by HGPI and key infectious disease stakeholders in Japan.
AMR Alliance Japan has worked with Alliance members and partner organizations to deepen policy debate around AMR. This work resulted in the July 2019 release of “AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting AMR Countermeasures.” Moving forward, the Alliance will take every opportunity to explain these recommendations to AMR policy stakeholders toward concrete policy action on AMR.
HGPI has hosted a number of meetings related to AMR over the past few years. HGPI is committed to promoting further, healthy debate on this pressing global issue.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)